DARUNAVIR Side Effects

7007115-2 | Oedema Peripheral
on Sep 10, 2010 Male patient from UNITED KINGDOM , weighting 191.8 lb, was diagnosed with hiv infection (What is hiv infection?), lower respiratory tract infection and was treated with Darunavir (View Usage). Patient experienced the following unwanted or unexpected effects: oedema peripheral. Darunavir dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), TRUVADA (View Truvada Review and Truvada Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ).

6962195-5 | Aortic Valve Sclerosis, Apnoea, Cardiac Arrest, Cardiac Murmur, Congenital Heart Valve Disorder, Large For Dates Baby, Neonatal Respiratory Arrest, Pulmonary Valve Sclerosis
Patient was taking Darunavir (View Usage). Patient had the following side effects: aortic valve sclerosis, apnoea, cardiac arrest (What is cardiac arrest?), cardiac murmur, congenital heart valve disorder, large for dates baby, neonatal respiratory arrest, pulmonary valve sclerosis on Aug 23, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 7.52 lb, . Darunavir dosage: . During the same period patient was treated with ISENTRESS (View Isentress Review and Isentress Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), TRUVADA (View Truvada Review and Truvada Label ).

6942358-5 | Cardiac Murmur, Congenital Heart Valve Disorder, Ventricular Hypertrophy
Adverse event was reported on Aug 13, 2010 by a Female patient taking Darunavir (View Usage) (Dosage: ) . Location: UNITED KINGDOM , weighting 7.52 lb, After Darunavir was administered, patient had the following side effects: cardiac murmur, congenital heart valve disorder, ventricular hypertrophy. During the same period patient was treated with RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6941924-0 | Aortic Valve Sclerosis, Apnoea, Cardiac Arrest, Cardiac Murmur, Congenital Heart Valve Disorder, Large For Dates Baby, Neonatal Respiratory Arrest, Pulmonary Valve Sclerosis
on Aug 17, 2010 Female patient from UNITED KINGDOM , weighting 7.52 lb, was treated with Darunavir (View Usage). Patient experienced the following unwanted or unexpected effects: aortic valve sclerosis, apnoea, cardiac arrest (What is cardiac arrest?), cardiac murmur, congenital heart valve disorder, large for dates baby, neonatal respiratory arrest, pulmonary valve sclerosis. Darunavir dosage: . During the same period patient was treated with ISENTRESS (View Isentress Review and Isentress Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), TRUVADA (View Truvada Review and Truvada Label ).


6938156-9 | Pneumonia, Renal Failure Acute
on Aug 13, 2010 Male patient from UNITED STATES , weighting 141.5 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Darunavir (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?), renal failure acute. Darunavir dosage: . During the same period patient was treated with EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (View Emtricitabine/tenofovir Disoproxil Fumarate Review and Emtricitabine/tenofovir Disoproxil Fumarate Label ), NORVIR (View Norvir Review and Norvir Label ). Patient was hospitalized.

6933997-6 | Aortic Valve Sclerosis, Apnoea, Cardiac Arrest, Cardiac Murmur, Congenital Heart Valve Disorder, Large For Dates Baby, Neonatal Respiratory Arrest, Pulmonary Valve Sclerosis
Patient was taking Darunavir (View Usage). After Darunavir was administered, patient had the following side effects: aortic valve sclerosis, apnoea, cardiac arrest (What is cardiac arrest?), cardiac murmur, congenital heart valve disorder, large for dates baby, neonatal respiratory arrest, pulmonary valve sclerosis on Aug 11, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 7.52 lb, . Darunavir dosage: . During the same period patient was treated with ISENTRESS (View Isentress Review and Isentress Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), TRUVADA (View Truvada Review and Truvada Label ).

6922954-1 | Cardiac Murmur, Congenital Heart Valve Disorder, Ventricular Hypertrophy
Adverse event was reported on Aug 04, 2010 by a Female patient taking Darunavir (View Usage) (Dosage: ) . Location: UNITED KINGDOM , weighting 7.52 lb, Patient experienced the following unwanted or unexpected effects: cardiac murmur, congenital heart valve disorder, ventricular hypertrophy. During the same period patient was treated with RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE TABLETS (View Zidovudine Tablets Review and Zidovudine Tablets Label ).

6913421-X | Apnoea, Cardiac Murmur, Congenital Heart Valve Disorder, Ventricular Hypertrophy
on Jul 29, 2010 Female patient from UNITED KINGDOM , weighting 7.52 lb, was treated with Darunavir (View Usage). Patient had the following side effects: apnoea, cardiac murmur, congenital heart valve disorder, ventricular hypertrophy. Darunavir dosage: . During the same period patient was treated with ISENTRESS (View Isentress Review and Isentress Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), TRUVADA (View Truvada Review and Truvada Label ).

6908985-6 | Cardiac Murmur, Congenital Heart Valve Disorder, Ventricular Hypertrophy
on Jul 28, 2010 Female patient from UNITED KINGDOM , weighting 7.52 lb, was treated with Darunavir (View Usage). After Darunavir was administered, patient had the following side effects: cardiac murmur, congenital heart valve disorder, ventricular hypertrophy. Darunavir dosage: . During the same period patient was treated with RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6882068-6 | Cardiac Murmur, Congenital Heart Valve Disorder, Ventricular Hypertrophy
Patient was taking Darunavir (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac murmur, congenital heart valve disorder, ventricular hypertrophy on Jul 23, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 7.52 lb, . Darunavir dosage: . During the same period patient was treated with RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6810353-2 | Abdominal Distension, Rash, Swelling Face
Adverse event was reported on Jun 17, 2010 by a Female patient taking Darunavir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: SPAIN , 50 years of age, Patient had the following side effects: abdominal distension, rash (What is rash?), swelling face. During the same period patient was treated with ETRAVIRINE (View Etravirine Review and Etravirine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ).

6767106-3 | Cardiac Arrest
on Jun 03, 2010 Female patient from UNITED KINGDOM , weighting 143.3 lb, was diagnosed with hiv infection (What is hiv infection?), depression (What is depression?) and was treated with Darunavir (View Usage). After Darunavir was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?). Darunavir dosage: . During the same period patient was treated with KIVEXA (View Kivexa Review and Kivexa Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6766414-X | Blood Cholesterol Increased, Oedema, Weight Increased
on Jun 02, 2010 Male patient from UNITED KINGDOM , 45 years of age, weighting 172.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Darunavir (View Usage). Patient experienced the following unwanted or unexpected effects: blood cholesterol increased, oedema, weight increased. Darunavir dosage: . During the same period patient was treated with ETRAVIRINE (View Etravirine Review and Etravirine Label ), ISENTRESS (View Isentress Review and Isentress Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), CACIT D3 (View Cacit D3 Review and Cacit D3 Label ), DAPSONE (View Dapsone Review and Dapsone Label ), DOCUSATE SODIUM (View Docusate Sodium Review and Docusate Sodium Label ).

6751846-6 |
Patient was taking Darunavir (View Usage). on May 26, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 49 years of age, weighting 143.3 lb, was diagnosed with hiv infection (What is hiv infection?), depression (What is depression?) and. Darunavir dosage: . During the same period patient was treated with KIVEXA (View Kivexa Review and Kivexa Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6749938-0 | Erythema Multiforme
Adverse event was reported on May 21, 2010 by a Male patient taking Darunavir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: SPAIN , 47 years of age, After Darunavir was administered, patient had the following side effects: erythema multiforme. During the same period patient was treated with KIVEXA (View Kivexa Review and Kivexa Label ), KONAKION (View Konakion Review and Konakion Label ), EVENING PRIMROSE OIL (View Evening Primrose Oil Review and Evening Primrose Oil Label ), LORMETAZEPAM (View Lormetazepam Review and Lormetazepam Label ), NOCTAMID (View Noctamid Review and Noctamid Label ), HUMATIN (View Humatin Review and Humatin Label ), NORVIR (View Norvir Review and Norvir Label ).

6749937-9 | Cardiac Arrest
on May 26, 2010 Female patient from UNITED KINGDOM , weighting 143.3 lb, was diagnosed with hiv infection (What is hiv infection?), depression (What is depression?) and was treated with Darunavir (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?). Darunavir dosage: . During the same period patient was treated with KIVEXA (View Kivexa Review and Kivexa Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6749936-7 | Cardiac Arrest, Myocardial Infarction
on May 26, 2010 Female patient from UNITED KINGDOM , weighting 143.3 lb, was diagnosed with hiv infection (What is hiv infection?), depression (What is depression?) and was treated with Darunavir (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), myocardial infarction. Darunavir dosage: . During the same period patient was treated with KIVEXA (View Kivexa Review and Kivexa Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6737343-2 | Myocardial Infarction
Patient was taking Darunavir (View Usage). After Darunavir was administered, patient had the following side effects: myocardial infarction on May 10, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 50 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Darunavir dosage: . During the same period patient was treated with KIVEXA (View Kivexa Review and Kivexa Label ), SSRI (View Ssri Review and Ssri Label ).

6735560-9 | Arrhythmia, Hyperthermia
Adverse event was reported on May 10, 2010 by a Female patient taking Darunavir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), depression (What is depression?) and. Location: UNITED KINGDOM , 49 years of age, weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), hyperthermia. During the same period patient was treated with KIVEXA (View Kivexa Review and Kivexa Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6709736-0 | Apnoea, Cardiac Murmur, Congenital Heart Valve Disorder, Ventricular Hypertrophy
on Apr 29, 2010 Female patient from UNITED KINGDOM , weighting 7.52 lb, was treated with Darunavir (View Usage). Patient had the following side effects: apnoea, cardiac murmur, congenital heart valve disorder, ventricular hypertrophy. Darunavir dosage: . During the same period patient was treated with ISENTRESS (View Isentress Review and Isentress Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), TRUVADA (View Truvada Review and Truvada Label ).

6696329-7 | Acute Myocardial Infarction
on Apr 15, 2010 Male patient from SPAIN , weighting 143.3 lb, was diagnosed with hiv infection (What is hiv infection?), dyslipidaemia and was treated with Darunavir (View Usage). After Darunavir was administered, patient had the following side effects: acute myocardial infarction. Darunavir dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), ABACAVIR (View Abacavir Review and Abacavir Label ), KIVEXA (View Kivexa Review and Kivexa Label ), LIPID MODIFYING AGENTS (View Lipid Modifying Agents Review and Lipid Modifying Agents Label ).

6688267-0 | Acute Haemorrhagic Conjunctivitis, Anaemia, Eye Disorder, Liver Function Test Abnormal, Paraesthesia, Toxic Epidermal Necrolysis
Patient was taking Darunavir (View Usage). Patient experienced the following unwanted or unexpected effects: acute haemorrhagic conjunctivitis, anaemia, eye disorder, liver function test abnormal, paraesthesia, toxic epidermal necrolysis on Apr 09, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 49 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Darunavir dosage: . During the same period patient was treated with ETRAVIRINE (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), KALETRA (View Kaletra Review and Kaletra Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ATAZANAVIR (View Atazanavir Review and Atazanavir Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), ABACAVIR (View Abacavir Review and Abacavir Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6684239-0 | Apnoea, Cardiac Murmur, Congenital Heart Valve Disorder
Adverse event was reported on Apr 07, 2010 by a Female patient taking Darunavir (View Usage) (Dosage: ) . Location: UNITED KINGDOM , weighting 7.52 lb, Patient had the following side effects: apnoea, cardiac murmur, congenital heart valve disorder. During the same period patient was treated with ISENTRESS (View Isentress Review and Isentress Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6665718-9 | Hyperlipidaemia, Proteinuria, Type 2 Diabetes Mellitus
on Mar 24, 2010 Female patient from UNITED KINGDOM , weighting 132.3 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Darunavir (View Usage). After Darunavir was administered, patient had the following side effects: hyperlipidaemia, proteinuria, type 2 diabetes mellitus. Darunavir dosage: . During the same period patient was treated with ETRAVIRINE (View Etravirine Review and Etravirine Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), MARAVIROC (View Maraviroc Review and Maraviroc Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6653926-2 | Abdominal Distension, Nausea, Stevens-johnson Syndrome, Viral Load Increased, Weight Decreased
on Mar 16, 2010 Male patient from UNITED KINGDOM , 41 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Darunavir (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, nausea (What is nausea?), stevens-johnson syndrome, viral load increased, weight decreased. Darunavir dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), MARAVIROC (View Maraviroc Review and Maraviroc Label ). Patient was hospitalized.

6602932-2 | Oedema, Weight Increased
Patient was taking Darunavir (View Usage). Patient had the following side effects: oedema, weight increased on Feb 17, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 45 years of age, weighting 172.0 lb, was diagnosed with hiv infection (What is hiv infection?) and. Darunavir dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), ISENTRESS (View Isentress Review and Isentress Label ), ETRAVIRINE (View Etravirine Review and Etravirine Label ).

6591374-4 | Altered State Of Consciousness
Adverse event was reported on Feb 08, 2010 by a Female patient taking Darunavir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , 36 years of age, After Darunavir was administered, patient had the following side effects: altered state of consciousness. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), ABACAVIR (View Abacavir Review and Abacavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ). Patient was hospitalized.

6588780-0 | Hyperlipidaemia, Proteinuria, Type 2 Diabetes Mellitus
on Feb 09, 2010 Female patient from UNITED KINGDOM , 49 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Darunavir (View Usage). Patient experienced the following unwanted or unexpected effects: hyperlipidaemia, proteinuria, type 2 diabetes mellitus. Darunavir dosage: . During the same period patient was treated with ETRAVIRINE (View Etravirine Review and Etravirine Label ), TRUVADA (View Truvada Review and Truvada Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), MARAVIROC (View Maraviroc Review and Maraviroc Label ).

6585564-4 | Hepatitis B
on Feb 05, 2010 Female patient from FRANCE , 25 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Darunavir (View Usage). Patient had the following side effects: hepatitis b (What is hepatitis b?). Darunavir dosage: . During the same period patient was treated with ETRAVIRINE (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6521309-1 | Myocardial Infarction
Patient was taking Darunavir (View Usage). After Darunavir was administered, patient had the following side effects: myocardial infarction on Dec 15, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 132.3 lb, was diagnosed with hiv infection (What is hiv infection?), gastrooesophageal reflux disease, hyperlipidaemia, asthma (What is asthma?) and. Darunavir dosage: . During the same period patient was treated with MARAVIROC (View Maraviroc Review and Maraviroc Label ), NORVIR (View Norvir Review and Norvir Label ), VIREAD (View Viread Review and Viread Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), CRESTOR (View Crestor Review and Crestor Label ), SERETIDE (View Seretide Review and Seretide Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6503631-8 | Myocardial Infarction
Adverse event was reported on Dec 15, 2009 by a Male patient taking Darunavir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), gastrooesophageal reflux disease, hyperlipidaemia, asthma (What is asthma?) and. Location: UNITED STATES , weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: myocardial infarction. During the same period patient was treated with MARAVIROC (View Maraviroc Review and Maraviroc Label ), NORVIR (View Norvir Review and Norvir Label ), VIREAD (View Viread Review and Viread Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), CRESTOR (View Crestor Review and Crestor Label ), SERETIDE (View Seretide Review and Seretide Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6463746-X | Haemodialysis, Pneumonia, Pneumonia Staphylococcal, Renal Failure Acute, Toxic Epidermal Necrolysis
on Nov 19, 2009 Male patient from UNITED STATES , 42 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Darunavir (View Usage). Patient had the following side effects: haemodialysis, pneumonia (What is pneumonia?), pneumonia staphylococcal, renal failure acute, toxic epidermal necrolysis. Darunavir dosage: . During the same period patient was treated with ABACAVIR + LAMIVUDINE (View Abacavir + Lamivudine Review and Abacavir + Lamivudine Label ). Patient was hospitalized.

6441570-1 | Anaemia, Hypoglycaemia, Hypothyroidism, Pneumonia, Renal Failure Acute
on Nov 02, 2009 Male patient from UNITED STATES , weighting 104.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Darunavir (View Usage). After Darunavir was administered, patient had the following side effects: anaemia, hypoglycaemia, hypothyroidism, pneumonia (What is pneumonia?), renal failure acute. Darunavir dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), ALINIA (View Alinia Review and Alinia Label ), DAPSONE (View Dapsone Review and Dapsone Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

6428667-7 | Anaemia, Hypoglycaemia, Hypothyroidism, Pneumonia, Renal Failure Acute
Patient was taking Darunavir (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, hypoglycaemia, hypothyroidism, pneumonia (What is pneumonia?), renal failure acute on Nov 02, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 104.0 lb, was diagnosed with hiv infection (What is hiv infection?) and. Darunavir dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), ALINIA (View Alinia Review and Alinia Label ), DAPSONE (View Dapsone Review and Dapsone Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

6428666-5 | Ileitis, Immune Reconstitution Syndrome, Mycobacterium Avium Complex Infection
Adverse event was reported on Oct 27, 2009 by a Male patient taking Darunavir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , weighting 187.6 lb, Patient had the following side effects: ileitis, immune reconstitution syndrome, mycobacterium avium complex infection. During the same period patient was treated with MARAVIROC (View Maraviroc Review and Maraviroc Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), NORVIR (View Norvir Review and Norvir Label ), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (View Emtricitabine And Tenofovir Disoproxil Fumarate Review and Emtricitabine And Tenofovir Disoproxil Fumarate Label ), REGLAN (View Reglan Review and Reglan Label ), TESTOSTERONE (View Testosterone Review and Testosterone Label ), INSULIN (View Insulin Review and Insulin Label ), TENORMIN (View Tenormin Review and Tenormin Label ). Patient was hospitalized.

6410332-3 | Alveolitis Allergic, Decreased Appetite, Dehydration, Diarrhoea, Encephalopathy, Gastric Ulcer, Gastrointestinal Disorder, Hepatotoxicity, Hypersensitivity
on Oct 16, 2009 Female patient from UNITED STATES , 42 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Darunavir (View Usage). After Darunavir was administered, patient had the following side effects: alveolitis allergic, decreased appetite, dehydration, diarrhoea, encephalopathy, gastric ulcer, gastrointestinal disorder, hepatotoxicity, hypersensitivity. Darunavir dosage: . During the same period patient was treated with ETRAVIRINE (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ). Patient was hospitalized.

6400176-0 | Ascites, Intra-abdominal Haemorrhage
on Oct 05, 2009 Female patient from UNITED STATES , weighting 150.6 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Darunavir (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, intra-abdominal haemorrhage. Darunavir dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), MARAVIROC (View Maraviroc Review and Maraviroc Label ). Patient was hospitalized.

6377331-1 | Anaemia, Hypoglycaemia, Hypothyroidism, Pneumonia, Renal Failure Acute
Patient was taking Darunavir (View Usage). Patient had the following side effects: anaemia, hypoglycaemia, hypothyroidism, pneumonia (What is pneumonia?), renal failure acute on Sep 21, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 104.0 lb, was diagnosed with hiv infection (What is hiv infection?) and. Darunavir dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), ALINIA (View Alinia Review and Alinia Label ), DAPSONE (View Dapsone Review and Dapsone Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

6368016-6 | Hepatitis B
Adverse event was reported on Sep 17, 2009 by a Male patient taking Darunavir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), hypertension, prophylaxis and. Location: UNITED STATES , 58 years of age, weighting 230.0 lb, After Darunavir was administered, patient had the following side effects: hepatitis b (What is hepatitis b?). During the same period patient was treated with ETRAVIRINE (View Etravirine Review and Etravirine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), COZAAR (View Cozaar Review and Cozaar Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), TOCOPHEROL CONCENTRATE CAP (View Tocopherol Concentrate Cap Review and Tocopherol Concentrate Cap Label ), COENZYME Q10 (View Coenzyme Q10 Review and Coenzyme Q10 Label ).

6366945-0 | Anaemia, Hypoglycaemia, Hypothyroidism, Pneumonia, Renal Failure Acute
on Sep 16, 2009 Male patient from UNITED STATES , weighting 104.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Darunavir (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, hypoglycaemia, hypothyroidism, pneumonia (What is pneumonia?), renal failure acute. Darunavir dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), ALINIA (View Alinia Review and Alinia Label ), DAPSONE (View Dapsone Review and Dapsone Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

6361119-1 | Hepatitis E, Therapeutic Response Decreased
on Sep 08, 2009 Male patient from FRANCE , 50 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Darunavir (View Usage). Patient had the following side effects: hepatitis e, therapeutic response decreased. Darunavir dosage: . During the same period patient was treated with TENOFOVIR (View Tenofovir Review and Tenofovir Label ), EMTRICITABINE (View Emtricitabine Review and Emtricitabine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6348550-5 | Alveolitis Allergic, Decreased Appetite, Dehydration, Diarrhoea, Encephalopathy, Gastric Ulcer, Gastrointestinal Disorder, Hepatotoxicity, Hypersensitivity
Patient was taking Darunavir (View Usage). After Darunavir was administered, patient had the following side effects: alveolitis allergic, decreased appetite, dehydration, diarrhoea, encephalopathy, gastric ulcer, gastrointestinal disorder, hepatotoxicity, hypersensitivity on Sep 01, 2009 from UNITED STATES Additional patient health information: Female patient , 42 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Darunavir dosage: . During the same period patient was treated with ETRAVIRINE (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ). Patient was hospitalized.

6348531-1 | Anaemia, Hypoglycaemia, Hypothyroidism, Renal Failure Acute
Adverse event was reported on Sep 03, 2009 by a Male patient taking Darunavir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , weighting 104.0 lb, Patient experienced the following unwanted or unexpected effects: anaemia, hypoglycaemia, hypothyroidism, renal failure acute. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), ALINIA (View Alinia Review and Alinia Label ), DAPSONE (View Dapsone Review and Dapsone Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

6345802-X | Hypersensitivity, Off Label Use
on Jul 13, 2009 Female patient from SPAIN , 17 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Darunavir (View Usage). Patient had the following side effects: hypersensitivity, off label use. Darunavir dosage: . During the same period patient was treated with ENFUVIRTIDE (View Enfuvirtide Review and Enfuvirtide Label ).

6337402-2 | Insomnia, Memory Impairment
on Aug 24, 2009 Male patient from UNITED KINGDOM , 25 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Darunavir (View Usage). After Darunavir was administered, patient had the following side effects: insomnia, memory impairment. Darunavir dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6328891-8 | Insomnia, Memory Impairment
Patient was taking Darunavir (View Usage). Patient experienced the following unwanted or unexpected effects: insomnia, memory impairment on Aug 18, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 25 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Darunavir dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6317908-2 | Alveolitis Allergic, Decreased Appetite, Dehydration, Diarrhoea, Encephalopathy, Gastric Ulcer, Gastrointestinal Disorder, Hepatotoxicity, Hypersensitivity
Adverse event was reported on Jul 23, 2009 by a Female patient taking Darunavir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 42 years of age, Patient had the following side effects: alveolitis allergic, decreased appetite, dehydration, diarrhoea, encephalopathy, gastric ulcer, gastrointestinal disorder, hepatotoxicity, hypersensitivity. During the same period patient was treated with ETRAVIRINE (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ). Patient was hospitalized.

6317453-4 | Hepatitis B
on Jul 23, 2009 Male patient from UNITED STATES , 58 years of age, weighting 230.0 lb, was diagnosed with hiv infection (What is hiv infection?), hypertension, prophylaxis and was treated with Darunavir (View Usage). After Darunavir was administered, patient had the following side effects: hepatitis b (What is hepatitis b?). Darunavir dosage: . During the same period patient was treated with ETRAVIRINE (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), COZAAR (View Cozaar Review and Cozaar Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), TOCOPHEROL CONCENTRATE CAP (View Tocopherol Concentrate Cap Review and Tocopherol Concentrate Cap Label ), COENZYME Q10 (View Coenzyme Q10 Review and Coenzyme Q10 Label ).

6314702-3 | Neutropenia, Thrombocytopenia
on Jul 23, 2009 Female patient from UNITED STATES , weighting 116.4 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Darunavir (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia, thrombocytopenia. Darunavir dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), MARAVIROC (View Maraviroc Review and Maraviroc Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), VALGANCICLOVIR HCL (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ), SEPTRA DS (View Septra Ds Review and Septra Ds Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), PEPCID (View Pepcid Review and Pepcid Label ). Patient was hospitalized.

6314586-3 | Acute Haemorrhagic Conjunctivitis, Anaemia, Liver Function Test Abnormal, Toxic Epidermal Necrolysis
Patient was taking Darunavir (View Usage). Patient had the following side effects: acute haemorrhagic conjunctivitis, anaemia, liver function test abnormal, toxic epidermal necrolysis on Aug 14, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 49 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Darunavir dosage: . During the same period patient was treated with ETRAVIRINE (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), KALETRA (View Kaletra Review and Kaletra Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ATAZANAVIR (View Atazanavir Review and Atazanavir Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), ABACAVIR (View Abacavir Review and Abacavir Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.